Your browser is no longer supported. Please, upgrade your browser.
Settings
CERS Cerus Corporation daily Stock Chart
CERS [NASD]
Cerus Corporation
Index- P/E- EPS (ttm)-0.62 Insider Own1.70% Shs Outstand102.74M Perf Week5.58%
Market Cap446.92M Forward P/E- EPS next Y-0.50 Insider Trans-0.96% Shs Float101.78M Perf Month-0.68%
Income-62.90M PEG- EPS next Q-0.17 Inst Own71.60% Short Float14.94% Perf Quarter2.11%
Sales39.30M P/S11.37 EPS this Y-6.20% Inst Trans0.25% Short Ratio17.48 Perf Half Y-13.17%
Book/sh0.56 P/B7.77 EPS next Y19.40% ROA-53.80% Target Price8.17 Perf Year-32.24%
Cash/sh0.70 P/C6.23 EPS next 5Y- ROE-87.30% 52W Range3.79 - 7.64 Perf YTD0.00%
Dividend- P/FCF- EPS past 5Y-11.80% ROI-79.90% 52W High-43.06% Beta1.86
Dividend %- Quick Ratio3.00 Sales past 5Y3.50% Gross Margin48.30% 52W Low14.78% ATR0.19
Employees204 Current Ratio3.50 Sales Q/Q23.70% Oper. Margin- RSI (14)52.86 Volatility5.38% 4.42%
OptionableYes Debt/Eq0.33 EPS Q/Q13.20% Profit Margin- Rel Volume0.58 Prev Close4.41
ShortableYes LT Debt/Eq0.21 EarningsMay 03 AMC Payout- Avg Volume869.74K Price4.35
Recom1.30 SMA202.17% SMA502.66% SMA200-16.42% Volume503,671 Change-1.36%
Jul-07-16Resumed Cantor Fitzgerald Buy $9
Dec-17-15Downgrade Wedbush Outperform → Neutral
May-02-14Reiterated MLV & Co Buy $8.50 → $6
Apr-24-13Reiterated Cantor Fitzgerald Buy $5.50 → $6
Mar-15-13Reiterated MLV & Co Buy $7.50 → $8.50
Apr-17-12Initiated Cantor Fitzgerald Buy $5.50
Feb-29-12Upgrade Robert W. Baird Neutral → Outperform $3 → $6
Nov-10-11Reiterated MLV & Co Buy $4 → $5
Jun-03-11Initiated Wedbush Outperform $4
Mar-04-11Downgrade Robert W. Baird Outperform → Neutral $4 → $3
Mar-09-10Upgrade Robert W. Baird Neutral → Outperform $3 → $5
Aug-26-09Upgrade Avondale Mkt Perform → Mkt Outperform $2 → $5
Jul-28-09Downgrade Robert W. Baird Outperform → Neutral $3
May-04-09Downgrade JMP Securities Mkt Perform → Mkt Underperform
Feb-27-09Downgrade Avondale Mkt Outperform → Mkt Perform
May-02-08Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-29-08Initiated JMP Securities Mkt Outperform
Dec-05-07Initiated Susquehanna Financial Neutral
May-02-07Downgrade JMP Securities Mkt Outperform → Mkt Perform
Feb-23-07Reiterated JMP Securities Mkt Outperform $17 → $9
Apr-24-17 03:13PM  Cerus Corp. Value Analysis (NASDAQ:CERS) : April 24, 2017 Capital Cube
Apr-21-17 08:46AM  Cerus Corp. breached its 50 day moving average in a Bullish Manner : CERS-US : April 21, 2017 Capital Cube
Apr-19-17 08:30AM  Cerus to Release First Quarter 2017 Results on May 3, 2017 Business Wire
Apr-07-17 10:57AM  Cerus Corporation (Nasdaq: CERS) to Ring the Nasdaq Stock Market Closing Bell Remotely from the Nasdaq Entrepreneurial Center in San Francisco GlobeNewswire
Apr-06-17 08:30AM  Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Apr-05-17 04:29PM  ETFs with exposure to Cerus Corp. : April 5, 2017 Capital Cube
08:22AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : April 5, 2017 Capital Cube
Mar-20-17 08:19AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : March 20, 2017 Capital Cube
Mar-14-17 01:04PM  CERUS CORP Financials
Mar-09-17 11:13AM  Cerus Corp. :CERS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 9, 2017 Capital Cube +5.88%
09:30AM  Biotech's Rally in 2017 Stumbles on Pricing Concerns: Today's Research Reports on Opko Health and Cerus Accesswire
Mar-08-17 04:46PM  CERUS CORP Files SEC form 10-K, Annual Report -5.78%
12:32PM  Edited Transcript of CERS earnings conference call or presentation 7-Mar-17 9:15pm GMT Thomson Reuters StreetEvents
Mar-07-17 04:44PM  Cerus reports 4Q loss Associated Press
04:05PM  CERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Cerus Corporation Reports Fourth Quarter and Year End 2016 Results Business Wire
09:00AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : March 7, 2017 Capital Cube
07:07AM  Q4 2016 Cerus Corp Earnings Release - After Market Close
Mar-02-17 08:30AM  Cerus to Present at the Cowen and Company 37th Annual Health Care Conference on March 8, 2017 Business Wire
Feb-21-17 08:30AM  Cerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017 Business Wire
Jan-20-17 04:18PM  Baron Funds Comments on Cerus Corp
Jan-04-17 08:30AM  Cerus Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Business Wire +5.77%
Dec-22-16 01:08PM  ETFs with exposure to Cerus Corp. : December 22, 2016
Dec-19-16 08:30AM  Cerus Provides an Update on the Timeline for the INTERCEPT Blood System for Red Blood Cells in Europe Business Wire
08:30AM  Cerus Announces Exercise of Additional BARDA Contract Options Totaling $10,825,555 for Activities Related to Its Planned Phase III Trial of the INTERCEPT Red Blood Cell System Business Wire
Dec-10-16 02:42PM  Do Hedge Funds Love Cerus Corporation (CERS)? at Insider Monkey
Nov-30-16 12:07PM  ETFs with exposure to Cerus Corp. : November 30, 2016
Nov-29-16 07:26AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : November 29, 2016
Nov-15-16 01:23PM  ETFs with exposure to Cerus Corp. : November 15, 2016
Nov-14-16 07:57AM  Cerus Corp. breached its 50 day moving average in a Bullish Manner : CERS-US : November 14, 2016
Nov-10-16 08:35AM  Is Cerus (CERS) Stock a Solid Choice Right Now?
Nov-04-16 04:53PM  Edited Transcript of CERS earnings conference call or presentation 3-Nov-16 8:15pm GMT +13.98%
04:06PM  CERUS CORP Files SEC form 10-Q, Quarterly Report
03:11PM  Cerus (CERS) Stock Surges on Q3 Results, Outlook
12:18PM  Why Cerus Corporation is Soaring Today at Motley Fool
Nov-03-16 05:11PM  Cerus reports 3Q loss -6.64%
04:05PM  CERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Cerus Corporation Reports Third Quarter 2016 Results Business Wire
07:07AM  Q3 2016 Cerus Corp Earnings Release - After Market Close
Nov-01-16 08:30AM  Cerus to Present at the Stephens 2016 Fall Investment Conference on November 8, 2016 Business Wire
Oct-21-16 09:50AM  ETFs with exposure to Cerus Corp. : October 21, 2016
Oct-20-16 08:30AM  Cerus to Release Third Quarter 2016 Results on November 3, 2016 Business Wire
Oct-13-16 08:30AM  Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application to the FDA to Allow for Interstate Export of INTERCEPT Platelet Components Business Wire -6.16%
Oct-10-16 08:30AM  Cerus Announces that Hemolife Fundación Banco Nacional de Sangre Has Entered into Routine Use of the INTERCEPT Blood System Business Wire
Oct-05-16 08:30AM  Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Sep-29-16 09:35AM  ETFs with exposure to Cerus Corp. : September 29, 2016 -6.28%
Sep-07-16 08:31AM  Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
08:30AM  Cerus to Present at the Morgan Stanley Global Healthcare Conference on September 14, 2016 Business Wire
Sep-01-16 08:30AM  Cerus to Present at the Baird 2016 Healthcare Conference on September 8, 2016 Business Wire
08:20AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : September 1, 2016
Aug-31-16 04:17PM  CERUS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Aug-29-16 11:29AM  Cerus INTERCEPT Blood System Among New Safety Measures Recommended By FDA
08:30AM  FDA's New Recommendation for Universal Zika Risk Reduction of Blood Components Includes Use of Pathogen Reduction Business Wire
Aug-27-16 01:11AM  UPDATE 4-FDA recommends Zika testing for all blood donated in U.S. Reuters
Aug-26-16 10:19AM  ETFs with exposure to Cerus Corp. : August 26, 2016
Aug-13-16 02:36PM  Which Stocks Are Impacted by the Rio Olympics?
Aug-12-16 01:24PM  Obama Moves Money Around To Keep Zika Research Going Amid Lack Of Congressional Funds Allocation
Aug-11-16 12:38PM  ETFs with exposure to Cerus Corp. : August 11, 2016
Aug-10-16 11:59AM  Buy the Dip During Dog Days at Investopedia
11:50AM  Cerus Corp. :CERS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 08:30AM  Vivek Jayaraman Appointed as Cerus Corporations Chief Commercial Officer Business Wire
Aug-08-16 05:03AM  Edited Transcript of CERS earnings conference call or presentation 4-Aug-16 8:15pm GMT -5.75%
Aug-06-16 12:11PM  Watch these biotechs as the Zika virus moves to the U.S. at MarketWatch
Aug-05-16 04:04PM  CERUS CORP Files SEC form 10-Q, Quarterly Report
Aug-04-16 05:33PM  Cerus reports 2Q loss
04:06PM  CERUS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  Cerus Corporation Reports Second Quarter 2016 Results Business Wire
07:07AM  Q2 2016 Cerus Corp Earnings Release - After Market Close
Aug-01-16 08:05AM  Cerus (CERS) in Focus: Stock Moves 6% Higher in Session
Jul-29-16 02:46PM  Friday's Zika Reports Explained: Winners And Losers +6.03%
Jul-21-16 08:30AM  Cerus to Release Second Quarter 2016 Results on August 4, 2016 Business Wire
Jul-19-16 12:45PM  Why These Stocks Are Gaining Ground on Tuesday? at Insider Monkey
Jul-11-16 08:30AM  Cerus Provides an Update on Adoption by Blood Centers of America Members for the INTERCEPT Blood System for Platelets and Plasma Business Wire
Jul-10-16 10:20AM  5 Analyst Stock Picks Under $10 With Massive Upside Calls at 24/7 Wall St.
Jul-08-16 01:39PM  CORRECTING and REPLACING Cerus to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference on July 13, 2016 Business Wire
Jul-06-16 08:30AM  Cerus and CEI Announce Donation of INTERCEPT Blood System Kits to HEMORIO for Emergency Preparedness Ahead of the Summer Olympic Games in Rio de Janeiro Business Wire
Jul-05-16 08:30AM  Cerus to Present at Cantor Fitzgeralds 2nd Annual Healthcare Conference on July 13, 2016 Business Wire
Jun-30-16 08:30AM  Cerus Corporation, the Transfusion Service of the Swiss Red Cross, and the University Hospital of Basel Receive a Grant of 2 Million Swiss Francs From the Swiss Red Cross Humanitarian Foundation for Whole Blood Pathogen Inactivation for Afr Business Wire
Jun-21-16 11:23AM  Cerus Corp. Value Analysis (NASDAQ:CERS) : June 21, 2016
Jun-20-16 12:41PM  Cerus Corporation is Surging Today. Here's Why. at Motley Fool +7.72%
10:58AM  Why Anthem, Cigna, Fiat Chrysler, and Two Other Stocks Are Trending Today at Insider Monkey
08:26AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : June 20, 2016
Jun-19-16 04:00PM  Cerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its INTERCEPT Red Blood Cell Program Business Wire
Jun-09-16 04:34PM  CERUS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
10:11AM  The Probable Reason Behind Cerus Corp's 11.2% Drop in May at Motley Fool
Jun-08-16 02:15PM  ETFs with exposure to Cerus Corp. : June 8, 2016
08:18AM  Cerus Corp. breached its 50 day moving average in a Bullish Manner : CERS-US : June 8, 2016
May-31-16 01:48PM  WHO Raises Abstinence/Safe-Sex Period To 8 Weeks For Individuals Returning From Zika Areas
May-23-16 08:30AM  Health Canada Approves INTERCEPT Blood System for Plasma Business Wire
May-12-16 03:28PM  ETFs with exposure to Cerus Corp. : May 12, 2016
May-11-16 09:23AM  Cerus Corp. :CERS-US: Earnings Analysis: Q1, 2016 By the Numbers
May-06-16 05:03PM  CERUS CORP Files SEC form 10-Q, Quarterly Report
May-05-16 09:03AM  Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : May 5, 2016
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, such as viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products. The company's INTERCEPT Blood Systems for platelets and plasma are designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It markets platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was founded in 1991 and is headquartered in Concord, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Greenman William MarinerPresident and CEOMar 15Sale4.218,78636,990316,938Mar 15 08:18 PM
Green Kevin DennisChief Financial OfficerMar 15Sale4.212,3439,86452,062Mar 15 08:17 PM
Moore CarolSVP Reg. & QualityMar 14Sale4.152,3779,86525,583Mar 15 08:24 PM
Menard ChrystalChief Legal OfficerMar 14Sale4.152,2599,3757,354Mar 15 08:21 PM
Benjamin Richard JChief Medical OfficerMar 14Sale4.151,1894,9341,832Mar 15 08:15 PM
Greenman William MarinerPresident and CEOSep 30Option Exercise5.5555,000305,250298,283Oct 03 06:04 AM
CORASH LAURENCE MChief Scientific OfficerSep 22Option Exercise5.5521,000116,5501,319,756Sep 23 06:13 PM
CORASH LAURENCE MChief Scientific OfficerSep 15Option Exercise5.559,00049,9501,298,756Sep 16 08:28 PM
Green Kevin DennisChief Financial OfficerAug 22Option Exercise4.6817,15080,22353,167Aug 24 05:47 PM
Green Kevin DennisChief Financial OfficerAug 22Sale6.8017,150116,61242,167Aug 24 05:47 PM